# Clustering Approach 3 : METHLYATION_CNMF
Index	Clinical feature name	Test type	P value	Comment
1	Time to Death	logrank test	0.256612085501116	Range of duration = 0.46 to 85.32, nDeath = 21, nCensor = 40
2	AGE	ANOVA	0.522568734338776	Range of values = 38 to 84, Mean = 65.4375, StdDev = 9.55332, nMissing = 2
3	GENDER	Fisher's exact test	0.404976579456134	nTypes = 2 (FEMALE/MALE), nPatients = 30/36
4	KARNOFSKY.PERFORMANCE.SCORE	ANOVA	0.206644203750808	Range of values = 0 to 100, Mean = 80, StdDev = 36.0555, nMissing = 59
5	HISTOLOGICAL.TYPE	Chi-square test	0.252074728453802	nTypes = 5 (LUNG ADENOCARCINOMA MIXED SUBTYPE/LUNG ADENOCARCINOMA- NOT OTHERWISE SPECIFIED (NOS)/LUNG CLEAR CELL ADENOCARCINOMA/LUNG MICROPAPILLARY ADENOCARCINOMA/LUNG PAPILLARY ADENOCARCINOMA), nPatients = 15/48/1/1/1
6	PATHOLOGY.T	Chi-square test	0.476839921753075	nTypes = 4 (T1/T2/T3/T4), nPatients = 16/41/6/3
7	PATHOLOGY.N	Chi-square test	0.899099715374786	nTypes = 3 (N0/N1/N2+N3), nPatients = 39/15/10, nMissing = 2
8	PATHOLOGICSPREAD(M)	Fisher's exact test	0.824646351136993	nTypes = 2 (M0/M1), nPatients = 59/6, nMissing = 1
9	RADIATIONS.RADIATION.REGIMENINDICATION	Fisher's exact test	0.505057442557418	nTypes = 2 (NO/YES), nPatients = 62/4
10	NEOADJUVANT.THERAPY	Fisher's exact test	0.0871447394843643	nTypes = 2 (NO/YES), nPatients = 54/12